Daily Stock List
Lithium Corp. (LTUM)
SmarTrend Newsletters reported recently on Lithium Corp. (LTUM), and today we choose to highlight the Company, here at the QualityStocks Daily Newsletter.
An exploration enterprise, Lithium Corp. engages in the identification, acquisition, and exploration of metals and minerals. Their focus is on lithium mineralization on properties in the state of Nevada. The Company explores and develops potentially economic lithium-enriched brine fields. Their corporate goal is to become a long-term producer of this increasingly strategic and economically important commodity. A junior mining company, Lithium lists on the OTCQB; the Company is based in Reno, Nevada.
The Company's current projects include Fish Lake Valley and San Emidio. At Fish Lake Valley, they hold Placer claims that cover approximately 6,400 acres. Fish Lake Valley is in West Central Nevada, in Northern Esmeralda County. At their flagship Fish Lake Valley property, near economic grades of lithium, potassium and boron have been discovered within a zone that measures one square mile in size. Lithium conducted a short drill program at Fish Lake during Fall 2012. Their intention is to do more work on this prospect this year, once surface conditions improve later in 2013.
Pertaining to San Emidio, the Company staked a 1,600-acre block of claims in the San Emidio Valley during September of 2011. These claims cover the most prospective portion of the playa. This is where ongoing sampling has determined anomalous concentrations of Lithium occur in sediments and in brines. The San Emidio Project is in northwestern Nevada, Washoe County. Lithium has outlined a strong northeasterly trending lithium anomaly at San Emidio; their intention is to conduct deeper tests - with drilling during this coming summer.
In March, Lithium announced that they staked strategically located claims at their Fish Lake Valley property in Esmeralda County. They became aware several months ago that certain claims held by a third party in the area of their most recent exploration work at Fish Lake Valley had been allowed to lapse. The Company immediately took steps to acquire a block of 320 acres via staking.
In April, Lithium announced that they signed an option agreement to acquire the Mount Heimdal Flake Graphite property in the Slocan Mining Division of British Columbia. The Mount Heimdal property consists of 3 mineral claims that include 2,582 acres (1,045 hectares) of highly metamorphosed rock. The property is approximately 6 miles (10 kms) south of Eagle Graphite's Black Crystal quarry. The property is within the same package of gneisses, graphite mineralized marbles, and calc-silicate gneisses.
Lithium Corp. (LTUM), closed Friday's trading session at $0.04, down 12.85%, on 13,300 volume with 6 trades. The average volume for the last 60 days is 65,085 and the stock's 52-week low/high is $0.04/$0.105.
Plandai Biotechnology, Inc. (PLPL)
PremiereStockAlerts, OTCJournal, Hot Stock Profits, and MyBestStockAlerts reported today on Plandai Biotechnology, Inc. (PLPL), and we are highlighting the Company as well, here at the QualityStocks Daily Newsletter.
Listed on the OTCQB, Plandai Biotechnology, Inc. and their subsidiaries develop highly bioavailable, phytonutrient rich extracts used to deliver a new family of drugs to treat - safely and affordably - a multitude of diseases and conditions. Targeted industries for their products include beverage, cosmeceutical, wellness, nutraceutical, as well as pharmaceutical. The Company's intention is to transform the world of nutraceuticals through making available extracts from live plant material that deliver the highest levels of bioavailability currently in the market. Plandai Biotechnology has their corporate headquarters in Seattle, Washington.
The Company controls every aspect of their process. This is from growing the raw materials on their farms in South Africa, to producing their patented Phytofare™ extracts in-house. Plandai's principle holdings consist of land, farms and infrastructure; these total over 8,500 acres, in the province of Mpumalanga, South Africa. The Company farms a whole range of produce that they use in their creation of highly bioavailable extracts. This produce ranges from citrus to avocado pears to more than 2,000 acres of tea.
Plandai Biotechnology intends to conduct scientific studies using their Green Tea Gallate Catechin Extract to authenticate previously published findings that green tea gallate catechins are a potential anti–malaria drug target. Phytofare™ products include Green Tea Gallate Catechin Extract (=95 percent HPLC); Lycopene, Phytofluene and Phytoene Extracts (=95 percent HPLC), and Citrus Bioflavonoid Citrus Limonoids Extracts (=95 percent HPLC).
This week, Plandai Biotechnology announced the formation of Phyto Pharmacare, Inc., a Delaware corporation. Phyto Pharmacare will oversee all aspects of developing and marketing Phytofare™ extracts for pharmaceutical and drug applications.
Furthermore, this week, the Company announced a distribution agreement that grants Natural Products the exclusive rights in South Africa to develop and market a weight management product using Plandai Biotechnology's Phytofare™ Catechin Extract. The Company's Phytofare™ Catechin Extract undergoes processing to deliver a highly bioavailable, antioxidant-rich material to a level many times that of other green tea extracts available on the market.
Plandai Biotechnology, Inc. (PLPL), closed Friday's trading session at $0.53, up 32.50%, on 303,834 volume with 132 trades. The average volume for the last 60 days is 26,190 and the stock's 52-week low/high is $0.04/$0.435.
Sauer Energy, Inc. (SENY)
PennyStockLocks.com, OTCPicks, Penny Stock Rumble, and PennyTrader Publisher reported earlier on Sauer Energy, Inc. (SENY), and we highlight the Company today, here at the QualityStocks Daily Newsletter.
Headquartered in Camarillo, California, Sauer Energy, Inc. is the developer of the patented WindCharger™ brand vertical axis wind turbine (VAWT) and manufacturer of the patented HelixWind® vertical axis wind turbine. The Company is a technology developer and manufacturer focusing on the emerging renewable energy market. Their technology, because it requires few parts, provides a new direction for wind capture, scales easily from residential to small community and up to large industrial scale. The Company has created the WindCharger™ model to provide a better solution for the use of wind capture for residential or small building use.
The WindCharger™ is one of Sauer Energy's key innovation priorities. The Company has several patents in place and more pending. The focus of the WindCharger™ and Helix turbines has centered on patented disruptive technology, minimum impact on the environment, mounting flexibility, and versatility with highly efficient output. Sauer and Helix turbines underwent development to produce a quiet and low-impact technology with a high output of sustainable renewable energy.
With the acquisition of the assets of Helix Wind, Sauer Energy plans to be able to offer the Helix vertical axis wind turbine systems in the near future. The design of them is specifically to be pole mounted and can respond to the demand for applications that do not require roof mounting.
Last month, Sauer Energy reported concerning WindCharger™ production. The Company's initial plan is to launch sales of the WindCharger™. Sauer and VEC Technology, LLC, are solidifying production plans and providing updates. The same is true of the other component and peripheral suppliers. All pre-production engineering requirements have been completed. Prototyping, testing, engineering for tooling and material specifications have all been completed and accurately calculated.
Pertaining to HelixWind® production, the Company plans to launch the HelixWind® turbines. Production and fulfillment of the Helix units will take place at Sauer Energy headquarters in Camarillo. The Company's engineers are developing production schedules for future launch and to meet current demand.
Sauer Energy, Inc. (SENY), closed Friday's trading session at $0.18, up 20.00%, on 386,338 volume with 90 trades. The average volume for the last 60 days is 242,618 and the stock's 52-week low/high is $0.0785/$0.389.
Typhoon Exploration, Inc. (TYP.V)
We are highlighting Typhoon Exploration, Inc. (TYP.V), here at the QualityStocks Daily Newsletter.
Listed on the TSX Venture Exchange, Typhoon Exploration, Inc. is a Canadian mineral exploration company with a varied portfolio of properties. Their business strategy is to use modern technology for exploration with a commitment to minimize their impact on the environment. The Company's intention is to continue their mission of exploration and development independently or in partnership. Established in 2003, Typhoon Exploration is based in Laval, Quebec.
The Company's properties include Fayolle, Faille 1, Monexco-McCorkill, Aiguebelle-Goldfields, Destorbelle, and Nordair. The Fayolle Property (100 percent owned) is approximately 35 km northeast of the town of Rouyn-Noranda. The property consists of 39 mining claims in the Aiguebelle and Clericy townships covering 1,373 hectares. The Faille 1 Property (100 percent-owned) is approximately 35 km northeast of the town of Rouyn-Noranda. Faille 1 consists of 27 mining claims situated in the townships of Cléricy and La Pause. These titles cover an area of 1,087 hectares.
The Monexco-McCorkill Property (100 percent owned) is approximately 30 km NE of Chibougamau. The property consists of 113 contiguous mining claims and cells covering an area of 1,815 hectares. The Aiguebelle-Goldfields Property (51 percent owned) is approximately 35 km northeast of the town of Rouyn-Noranda. The property consists of 6 mining claims in the Aiguebelle Township, covering an area of 253.85 hectares.
The Destorbelle Property (50 percent owned) is approximately 35 km northeast of the town of Rouyn-Noranda. The property consists of 24 contiguous mining claims, located at the junction of the Destor, Cléricy and Aiguebelle townships. It covers an area of 953.1 hectares. In addition, the Company's Nordair Property (100 percent owned) in Quebec is less than 100 km southwest from GoldCorp's Eleonor Project.
This week, Typhoon Exploration gave an update on the Fayolle Project. The Company entered into a joint venture, in 2010, with Aurizon Mines Ltd., for the development of the Fayolle Project, located 10 kilometers north of Aurizon's Joanna Project, in Quebec. The mineralized zones on the Fayolle Deposit have distribution along a major shear corridor of approximately 2.5 kilometers long by 1 kilometer wide.
The updated mineral resource estimate integrates the results of all the drill programs on the Fayolle Deposit since the mineral resource estimate prepared for Typhoon Exploration in 2007. The updated mineral resources are estimated at 1,814,800 tonnes at 2.7 grams of gold per tonne, or 156,000 ounces of gold at a minimum cut-off grade of 0.8 grams of gold per tonne. All of the updated mineral resources are in the indicated mineral resource category.
Typhoon Exploration, Inc. (TYP.V), closed Friday's trading session at $0.085, even for the day. The stock's 52-week low/high is $0.06/$0.33.
Harte Gold Corp. (HRT.TO)
Today we are reporting on Harte Gold Corp. (HRT.V), here at the QualityStocks Daily Newsletter.
Harte Gold Corp. is a gold exploration company whose shares trade on the Toronto Stock Exchange. The Company has interests in the Sugar Zone and Stoughton-Abitibi properties located in Ontario, Canada. Harte Gold is concentrating on the development of their 100 percent-owned Sugar Zone property. Currently, Harte is permitting an advanced exploration program for the Sugar Zone Deposit. Harte Gold has their headquarters in Toronto, Ontario.
The Sugar Zone Property is 60 kilometers east of the Hemlo Gold Camp. It holds an NI 43-101 compliant Indicated Resource of 980,900 tonnes, grading 10.13 g/t for 319,280 ounces of contained gold (uncapped) and grading 8.72 g/t Au for 274,970 ounces of contained gold (capped). This Property has an Inferred Resource of 580,500 tonnes, grading 8.36 g/t Au for 155,960 ounces of contained gold (uncapped) and grading 7.03 g/t Au for 131,280 ounces of contained gold (capped).
At the Sugar Zone Property, the design of the 2012 7,000m drill program was to target new ounces between the 400-600m levels and test a down-hole geophysics target between 800-1,000m.
The Company also holds the aforementioned Stoughton-Abitibi property situated on and next to the Destor-Porcupine Fault Zone. This is near the 2.5 million ounce Holt-Holloway Gold Mine in the Timmins, Ontario Porcupine gold camp.
Recently, Harte Gold provided an update of current operations at the Sugar Zone Property. Concerning VTEM Target Drilling, they completed a four-hole diamond drill program on the Ni-Cu VTEM anomaly located at the north end of the Dayhossarah Lake on Sugar Zone. Assays of the drill core contained minor amounts of nickel, copper, platinum and palladium. They discovered some higher-grade intersections of magnesium running up to 11 percent Mg and these were associated with biotite schists. The Company will perform no further work on this target at this time.
Harte Gold also gave a Sugar Zone Deposit bulk sample update. The Ministry of Northern Development and Mines accepted and filed their Closure Plan for the 70,000 tonne bulk sample. Harte Gold is proceeding with other permitting work associated with site preparation and underground development. The Company is currently conducting a 1,500 meter 7 diamond drill hole program to establish 35 meter pierce points and confirm the grade in the bulk sample area, and assay results will follow.
Harte Gold Corp. (HRT.V), closed Friday's trading session at $0.065, down 7.14%, on 476,000 volume. The stock's 52-week low/high is $0.06/$0.29.
Rainmaker Systems, Inc. (RMKR)
SmarTrend Newsletters reported earlier on Rainmaker Systems, Inc. (RMKR), Penny Detectives, Wall Street Resources, Stock Stars did previously, and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.
Based in Campbell, California, Rainmaker Systems, Inc. is a Commerce-as-a-Service (CaaS) company that lists on the NASDAQ Capital Market. The Company helps large enterprises gain greater market share and increased brand awareness for cloud-based or on-premise based product offerings in the global SMB market. A leading global cloud platform company, Rainmaker Systems provides customized multi-channel e-business solutions on a worldwide basis. These solutions support multiple payment methods, currencies and language capabilities. They can be enhanced with the Company's worldwide telesales agents.
Rainmaker helps large enterprises with an advanced e-Commerce open architecture SaaS platform that easily integrates cloud-based applications and on-premise applications with the Company's Global Commerce Services to provide their clients with a strategic collaboration. Rainmaker has a portfolio of B2B products, including their GrowCommerce B2B Storefront; their GrowCommerce for Renewals, and their ViewCentral Learning Management System (LMS).
The Rainmaker ViewCentral LMS platform is a SaaS cloud based on-demand training management system. It is available 24/7 with no software installation. The self-service platform is highly configurable. The design of the Rainmaker ViewCentral Learning Management Platform is specifically to automate time-consuming manual administration and maximize training participation. The ViewCentral Platform seamlessly manages training across all delivery methods through the Company's suite of products: Classroom, vClassroom, eLearning and Replay.
Recently, the Company announced that four new clients are now using the Rainmaker ViewCentral Learning Management Platform. These clients are using the platform to automate time-consuming manual training administration, maximize training participation, and generate more revenue from their worldwide training programs. The contracts for the four new customers range from 12- to 60-month licenses. The total combined value is approximately $2 million; all of the contracts are non-cancellable and will be pre-paid.
Today, Rainmaker Systems announced the appointment of Carmela Wong as Vice President (VP) of Marketing. Ms. Wong, an accomplished technology-industry marketing veteran, has rejoined Rainmaker to help propel the next stage of growth and capitalize on current market opportunities. She brings over 20 years of corporate, agency and client-side marketing experience to the Company management team; this includes serving as Rainmaker Systems' VP of Marketing from 2003 - 2008.
Rainmaker Systems, Inc. (RMKR), closed Friday's trading session at $0.5799, up 5.49%, on 73,252 volume with 333 trades. The average volume for the last 60 days is 71,309 and the stock's 52-week low/high is $0.38/$1.37.
Great China Mania Holdings, Inc. (GMEC)
ElitePennyStocks, PennyStocks24, Exclusive Stocks, Knock Out Penny Stocks, Penny King, Paradise Penny Stocks, Eastwind Research, PennyAuthority.com, Penny Lane Reports, AwesomePennyPicks, SmallCapAllStars, PennyStockLocks.com, StockLockandLoad, StockBomb.com, and StockRockandRoll reported recently on Great China Mania Holdings, Inc. (GMEC), and we highlight the Company, here at the QualityStocks Daily Newsletter.
Based in Kowloon, Hong Kong, Great China Mania Holdings, Inc. is an electronic content provider. They provide leisure and lifestyle related electronic contents by way of portal websites and major cell phone network operators. The Company also utilizes these electronic contents to produce traditional paper magazines. The Company previously went by the name Great East Bottles & Drinks (China) Holdings, Inc. They changed their name to Great China Mania Holdings, Inc. on March 16, 2011. Great China Mania lists on the OTC Markets' OTCQB.
To support the provision of electronic contents, the Company operates an artist management company to leverage the popularity of artists and celebrities in stories and events creations. Great China Mania, through their subsidiaries, involves in the provision of artist and project management services; publication of magazines; retail operation of video games and accessories; and investment activities.
Great China Mania organizes artists to participate in movies, event management, and promotions for their clients. The Company publishes eight weekly or bi-weekly magazines that specialize in computer technologies, video games, digital equipment, and automobiles. The Company operates two retail stores to sell video game machines, as well as video games and accessories.
Last month, Great China Mania announced that they signed a definitive formal co-director agreement with Mr. Cameron Hood, former co- director and co-creator of DreamWorks Animation. The agreement is to develop Great China Mania's movie business across the Asian markets. With this agreement, Mr. Hood shall co- direct a minimum of three movies with the Company over the next three years in Hong Kong, China and Asia.
Furthermore, in April, Great China Mania announced that they entered into an agreement with an individual non-affiliate third party to sell the Company's retail business segment, Great China Games Ltd. (GCG), in exchange for consideration of 3,000,000 shares of Great China Mania. The Company will cancel the 3,000,000 shares they receive from the non-affiliate third party upon completion of the transaction and thereby reduce the number of shares outstanding of the Company.
Great China Mania Holdings, Inc. (GMEC), closed Friday's trading session at $0.027, up 8.00%, on 2,401,750 volume with 38 trades. The average volume for the last 60 days is 700,161 and the stock's 52-week low/high is $0.0103/$0.65.
Lynas Corp. Ltd. (LYSDY)
Pro-Edge reported recently on Lynas Corp. Ltd. (LYSDY), Leeb's Market Forecast, Energy and Capital did previously, and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Lynas Corp. Ltd., together with their subsidiaries, engages in the exploration and development of rare earths deposits and mineral resources. The Company's strategy is to create a reliable, fully integrated source of Rare Earths from mine through to market, and to become the benchmark for the security of supply and environmental standards in the global Rare Earths industry. Lynas' lists on the OTCQX International; the Company has their headquarters in Sydney, Australia.
The foundation of Lynas' strategy is Mount Weld in Western Australia, the richest known deposit of Rare Earths in the world. Another foundation of their strategy is a state-of-the-art Rare Earths processing plant, the Lynas Advanced Materials Plant (LAMP), now under construction near Kuantan in Pahang, Malaysia. The Company holds interest in the Mount Weld project. This includes rare earths oxide deposits situated to the south of Laverton, Western Australia.
A bankable feasibility study, including pilot plants, was completed on the Rare Earths deposit at Mount Weld. The first mining campaign was completed on time and on budget. Lynas has completed construction of the Mount Weld Concentration Plant and first crushed ore was fed to the ball mill of the Concentration Plant on May 14, 2011. The Company is also involved in the planning, design, and construction of the aforementioned advanced materials processing plant for the production and distribution of rare earth oxides in Malaysia. In addition, Lynas has a strategic alliance with Sojitz Corp. for the Lynas Rare Earths project.
Construction of Phase 1 of the LAMP has been completed. At the end of November 2012, Lynas announced that first feed to kiln and commencement of operations were underway at LAMP.
In April, Lynas announced a Malaysian court update. The Company announced that the Federal Court - the highest Court in Malaysia - upheld the earlier decisions of lower Courts to dismiss an application by persons associated with the Save Malaysia Stop Lynas group (the Applicants) for an injunction against Lynas' Temporary Operating License (TOL). The Applicants' appeal was dismissed with costs.
Additionally, Lynas announced that the Court of Appeal confirmed the earlier decision of the Kuantan High Court to approve the Company's application to be joined as a party to the judicial review proceedings in the Kuantan High Court. The expectation is that those judicial review proceedings will be heard by the Kuantan High Court during this year.
Lynas Corp. Ltd. (LYSDY), closed Friday's trading session at $0.668, up 4.37%, on 126,823 volume with 29 trades. The average volume for the last 60 days is 84,922 and the stock's 52-week low/high is $0.455/$1.08.
The Aristocrat Group Corp. (ASCC)
The QualityStocks Daily Newsletter would like to spotlight The Aristocrat Group Corp. (ASCC). Today, The Aristocrat Group Corp. closed trading at $0.3423, up 14.10%, on 214,887 volume with 34 trades. The stock’s average daily volume over the past 60 days is 92,848, and its 52-week low/high is $0.25/$1.25.
The Aristocrat Group Corp. (ASCC) is a brand management company focused on providing premiere luxury goods through continual innovation. Luxuria Brands, a subsidiary of The Aristocrat Group, has been established to identify and promote unique brands that have mass market appeal across a diverse demographic.
Luxuria Brands is primarily concentrated on distilled spirits industries, with an initial focus on Vodka branding and marketing. The worldwide distilled spirits market is currently worth about $263 billion. In the U.S. alone, Vodka sales between 2004 and 2009 grew 25% from 13.9 million cases to 58.4 million cases. The clear liquor now accounts for almost a third of all distilled spirits consumed and continues to rise in popularity.
The Aristocrat Group is also pursuing opportunities in the women’s lifestyle industry. The World Bank recently estimated that the earning power of women will reach $18 trillion by 2014, which is twice the estimated 2014 GDP of China and India combined. The Aristocrat Group is working to bring fresh, innovative prenatal and postpartum solutions to women who are looking for a more comprehensive approach to wellness.
The Aristocrat Group is leveraging the marketing strengths of its team of experts to grow boutique products into powerful, recognizable brands. The company aims to take a leadership position in multiple growing markets that offer opportunities for partnership, sponsorship, and brand awareness activities. The Aristocrat Group is leveraging the marketing strengths of its team of experts to grow boutique products into powerful, recognizable brands. Disclaimer
The Aristocrat Group Corp. Company Blog
The Aristocrat Group Corp. News:
ASCC Targets Underserved Market for Gluten-Free Vodka
ASCC Details Its Keys to Profitability in $5.5 Billion U.S. Vodka Market
ASCC Aims to Expand Distribution North of the Border
Advaxis, Inc. (ADXS)
The QualityStocks Daily Newsletter would like to spotlight Advaxis, Inc. (ADXS). Today, Advaxis, Inc. closed trading at $0.052, up 4.00%, on 1,602,948 volume with 93 trades. The stock’s average daily volume over the past 60 days is 2,332,675, and its 52-week low/high is $0.0275/$0.155.
Advaxis, Inc. (ADXS) is a clinical-stage biotechnology company developing the next-generation of immunotherapies for cancer and infectious diseases. The company’s immunotherapies are based on a novel platform technology that uses live, bio-engineered bacteria to secrete an antigen/adjuvant fusion protein that redirects the powerful immune response all human beings have to fight off cancer and disease.
The company has more than fifteen distinct constructs in various stages of development, all of which are involved in strategic collaborations with recognized centers of excellence such as the National Cancer Institute, Cancer Research – UK, the Wistar Institute, the University of Pennsylvania, the University of British Columbia, the Karolinska Institutet, and others.
Advaxis’ lead construct, ADXS-HPV, is currently in Phase 2 clinical development for recurrent/refractory and advanced cervical cancer, CIN 2/3, and HPV caused head and neck cancers. This important construct was recognized as the Best Therapeutic Vaccine (approved or in development) at the 5th Annual Vaccine Industry Excellence (ViE) Awards by the vaccine industry and the journal Expert Reviews of Vaccines.
The estimated global market for immunotherapies is projected to exceed $37.2B by 2012, with cancer vaccines forecast to grow into an $8B market. Protected by 77 issued and pending patents, Advaxis is extremely well positioned to capitalize on the burgeoning opportunities in the healthcare sector as it advances the development of next-generation treatments for today’s most challenging diseases. Disclaimer
Advaxis, Inc. Company Blog
Advaxis, Inc. News:
Advaxis Announces 2013 Annual Meeting of Stockholders
Advaxis Announces Promotion of Dr. Robert Petit and Daniel J. O’Connor
Advaxis Reports Encouraging Preliminary Data from Penn Phase 1 ADXS-cHER2 Canine Osteosarcoma Study
VIASPACE, Inc. (VSPC)
The QualityStocks Daily Newsletter would like to spotlight VIASPACE, Inc. (VSPC). Today, VIASPACE, Inc. closed trading at $0.0152, up 0.66%, on 660,685 volume with 15 trades. The stock’s average daily volume over the past 60 days is 665,904, and its 52-week low/high is $0.0013/$0.0158.
VIASPACE, Inc. (VSPC) is focused on growing renewable Giant King™ Grass as a low-carbon fuel for clean electricity generation and environmentally friendly energy pellets, as well as a feedstock for bio-methane production, green cellulosic biofuels, biochemical, and biomaterials. A high-yield, low-cost feedstock, Giant King Grass meets the cost targets of green energy applications while maintaining a carbon neutral profile.
The highest yielding biomass crop in the world, Giant King Grass can grow in a variety of soil conditions and does not compete with food crops. Once Giant King Grass is established, it can be harvested at 3-5 feet tall every 45 to 60 days or at 14 feet tall twice a year. This incredibly high rate of growth provides a continual supply of biomass year-round, enabling strategically located power plants to operate 24 hours a day regardless of the current season.
VIASPACE provides Giant King™ Grass seedlings and technical expertise to qualified projects. The company also plans to serve as a project developer or co-developer for power plant or pellet mill projects, together with local partners that have land and require electricity, heat, pellets, biogas, or biofuels. VIASPACE and its partners are capable of delivering an integrated Giant King Grass plantation and biomass power plant project in just 24 months.
The excellent energy characteristics of Giant King Grass and its ability to be harvested multiple times each year enable and energy output yield that is much higher than other crops . This superior feedstock offers material productivity benefits at remarkable costs for energy production, biofuels, and biomaterials. Giant King Grass is currently being grown in the United States, Virgin Islands, China, and other areas. Disclaimer
VIASPACE, Inc. Company Blog
VIASPACE, Inc. News:
VIASPACE's Giant King Grass to Biogas for Electricity Paper Presented at International Biomass Conference
VIASPACE 7 MW Power Purchase Agreement Nearly Finalized in St. Croix, Giant King Grass Growing Well
VIASPACE and AGRICORP Partnership on Giant King Grass in Nicaragua: 12 MW Biomass Power Plant Targeted
International Stem Cell Corp. (ISCO)
The QualityStocks Daily Newsletter would like to spotlight International Stem Cell Corp. (ISCO). Today, International Stem Cell Corp. closed trading at $0.25, even with yesterday's close, on 13,829 volume with 9 trades. The stock’s average daily volume over the past 60 days is 114,101, and its 52-week low/high is $0.161/$0.45.
International Stem Cell Corp. (ISCO) specializes in the therapeutic applications of human parthenogenetic stem cells (hpSCs) and the development and commercialization of cell-based research and cosmetic products. The company was first to perfect the natural phenomenon of parthenogenesis, which utilizes unfertilized human eggs to create hpSCs. These stem cells, created in a particular form called HLA homozygous, can be immune-matched to millions of people regardless of sex or racial background, with minimal expectation of immune rejection after transplantation.
hpSCs are as pluripotent as embryonic stem cells (ESCs) and have significant therapeutic potential but their creation does not involve the destruction of a viable human embryo – thus sidestepping the controversy and ethical dilemmas associated with the use of human embryonic stem cells. Different from induced pluripotent stem cells (iPSs), hpSCs do not involve manipulation of gene expression back to a less differentiated stage – a practice that may become a safety or regulatory obstacle in clinical applications.
A relatively small number of hpSC lines can offer the potential of producing the first true stem cell bank, UniStemCell, which ISCO intends to create as a means of serving populations across the globe. The company's scientists are currently focused on using hpSC to treat severe diseases of the eye, nervous system, and liver, for which cell therapy has been clinically proven but is limited due to the unavailability of safe human cells.
In addition to its therapeutic focus, ISCO also provides two revenue streams. Firstly through its subsidiary Lifeline Cell Technology, specialized cells and growth media for biological research around the world, and secondly its subsidiary Lifeline Skin Care, the company manufactures and sells anti-aging skincare products utilizing an extract from the hpSC and by leveraging the latest discoveries in the fields of stem cell biology, nanotechnology, and skin cream formulation technology. Disclaimer
International Stem Cell Corp. Company Blog
International Stem Cell Corp. News:
International Stem Cell Corporation to Host Q1 2013 Financial Results Conference Call at 11:00 a.m. ET on Tuesday, May 14, 2013
International Stem Cell Corporation to Present at American Society of Gene and Cell Therapy 16th Annual Meeting
International Stem Cell Corporation Announces Fourth Quarter 2012 Financial Results and Provides Business Update
As hard as it may seem to believe, the American Diabetes Association says that over 8% of the U.S. population, roughly 1 out of 12 Americans, now has diabetes. That’s nearly 26 million people, though perhaps 1/4 of those afflicted have yet to be formally diagnosed with the disease. Even more chilling is the fact that almost 80 million people are estimated to have prediabetes, where blood glucose levels are higher than normal, but not yet at the level of type 2 diabetes. Such people are more likely to eventually develop diabetes.
In the U.S., diabetes costs almost a quarter of a trillion dollars annually, and is the cause, or a contributing factor, in nearly a quarter of a million deaths each year. The lack of exercise, as people spend more time in passive interface with electronics, coupled with high-carb diets, has led to an epidemic of obesity, leading in turn to an epidemic of diabetes.
Diabetes can produce a number of debilitating symptoms, two of which, cardiovascular disease and chronic wounds, are both directly targeted by California-based medical technology company Cardium Therapeutics.
Diabetes greatly increases the risk of heart disease and stroke, and Cardium’s primary development product Generx is an important angiogenic growth factor therapeutic for the treatment of cardiovascular disease. Unlike traditional drugs for treating heart disease, Generx is designed to actually increase blood flow around the heart. It is seen as being of value on a global basis, representing a far less costly or technically complex way of addressing heart disease. Generx can be administered non-surgically, using a standard cardiac infusion catheter, and it can stimulate the natural process of blood vessel growth in the heart’s microcirculation that is not reachable by surgical intervention. As such, it is a welcome alternative to elaborate and expensive surgical revascularization procedures, such as coronary artery bypass surgery and angioplasty/stents.
Cardium’s other important product for dealing with the problems of diabetes is Excellagen, an FDA-cleared wound treatment gel that has already been shown to significantly aid healing for many types of wounds, including diabetic foot ulcers. It’s easy to use and a number of physicians have reported observing a rapid onset of the growth of granulation tissue in a wide array of wounds, including classic non-healing diabetic foot ulcers. Cardium already has ISO certification to sell Excellagen in the U.S., and the company is now in the final commercialization stages for the product.
For additional information, visit www.CardiumTHX.com
Multichannel retailer ValueVision Media, operating as ShopNBC, announced the appointment of Robert S. Pick as Senior Vice President of Corporate Development of Comcast Corporation (NASDAQ: CMCSA) to its Board of Directors. Pick assumes the previous position of Catherine Dunleavy, following the increase of her responsibilities as EVP and CFO of Comcast’s NBC Universal Cable Entertainment Group.
Pick currently serves as Senior Vice President of Corporate Development of Comcast Corporation. He oversees the company’s corporate development as well as all merger and acquisition activities. Pick first joined the Comcast family in 1989 and has since played an invaluable role in shaping Comcast’s overall strategic vision.
Through its ownership of NBC Universal, Comcast has an ownership stake of more than 7.1 million ValueVision shares, representing approximately 14.5% of the total ValueVision shares outstanding.
“It gives me great pleasure to welcome Bob to our Board,” stated ValueVision Media Chairman Randy Ronning. “He has an impressive background in strategic corporate development coupled with a comprehensive understanding of our multichannel retailing space. We look forward to benefiting from his insights and experience to enhance shareholder value.”
Previously holding various esteemed financial positions with Bell Atlantic, as well as with KPMG Peat Marwick, Pick has in addition served on the Boards of several Comcast companies and charitable organizations. Pick’s resume includes overseeing the acquisition of AT&T Broadband, the unwinding of Comcast’s stake in Time Warner Cable, and acquisitions of the cable assets of Adelphia Communications, Maclean Hunter, EW Scripps, and Jones Cable. He is a graduate of Drexel University with a BS in finance and accounting, as well as serves on the President’s Leadership Council of Drexel University, and additionally has served on the LeBow Accounting Department Advisory Board.
Pick enthusiastically commented, “I am delighted to be joining ValueVision’s Board of Directors and look forward to working with Randy and the rest of the Board.”
Oclaro, an accomplished supplier and innovator in the optical communications and laser solutions market, announced today that it has released its HL63163DG red laser diode at 633 nm wavelength providing 100 mW single-transverse-mode optical output power for use in the biomedical, inspection, and measurement marketplace. The Oclaro HL63163DG red laser offers a compressed alternative to customers seeking a more compact option relative to the existing bulky Helium-Neon (He-Ne) gas lasers that are less energy efficient.
The development of the HL63163DG laser was centered on enabling system designers to increase the measurement accuracy, stability, and speed essential for biomedical and inspection applications. By leveraging existing technologies used for Oclaro lasers in the 637 to 642 nm range, Oclaro was able to provide these performance increases while also reducing footprint and power consumption. The level of performance achieved by the HL63163DG laser is typically associated only with large He-Ne gas lasers. Specifically, Oclaro’s new laser delivers low power consumption of only 0.4 W while operating at 100 mW in the 633 nm wavelength band, and comes in a highly-compact 5.6 mm-diameter TO industry-standard package.
“We expect to see the HL63163DG laser cannibalize the He-Ne gas lasers market since we’ve been able to shrink the laser size and lower the power consumption without compromising the performance attributes needed for the biomedical and inspection markets,” said Takayuki Kanno, President, Oclaro Japan and GM of the Modules and Devices Business Unit. “The industry has long been waiting on a semiconductor laser solution, and Oclaro was able to overcome the design challenges to offer a laser diode capable of delivering a high power 633 nm beam.”
Oclaro’s portfolio of high performance, visible, and near-infrared laser diode products is one of the most expansive in the industry, containing lasers ranging from 1 mW to 2 kW, and 405 nm to 1500 nm, founded on over 30 years of innovative laser heritage. The company will showcase its portfolio of visible and near-infrared laser devices, and VCSEL products and technology at the Laser World of Photonics conference, May 13-16, 2013, at the Messe Munchen Trade Fair Center in Munich, Germany.
For further information, please visit www.oclaro.com
Monster Offers, a Daily Deal analytics provider and mobile marketing advertising consulting firm, yesterday said its CEO, Wayne Irving II, will participate on a panel of judges for a national contest and related workshop this June in Anaheim, Calif., for Future Business Leaders of America’s National Leadership Conference.
Future Business Leaders of America-Phi Beta Lambda (FBLA) is a nonprofit student organization that aims to connect business and education through career development programs and leadership training. FLBA has more than 6,000 chapters across the country and more than 250,000 members ranging from middle school students to adult professionals.
“As an alumnus of FBLA myself, I was honored when asked to be a judge and speak at their upcoming National Leadership Conference,” Wayne Irving II, CEO of Monster Offers stated in the press release. “Monster Offers is committed to being on the cutting edge of upcoming technology trends, and we believe that being connected with today’s youth, particularly future business leaders, gives us an inside track toward understanding, as well as a unique perspective for evaluating, the burgeoning market demand for our technologies.”
Irving, a father of three teenagers, said, “I see my involvement with educational events impacting this age group both as a great way to give back to the community and as an invaluable resource for Monster Offers in terms of identifying, studying, and assessing important consumer and customer trends.”
FBLA’s National Awards Program highlights and rewards excellence in a broad range of business and career-related areas by allowing students to compete by testing their business knowledge and skills. Top state winners are eligible to compete for honors at the annual National Leadership Conference.
For more information, visit www.monsteroffer.com
Today's Top 3
The Green Baron
The QualityStocks Public Company Sponsor News
- Get profiles for new featured companies at clients.qualitystocks.net
- Advaxis, Inc. (ADXS) Announces 2013 Annual Meeting of Stockholders
- Consorteum Holdings, Inc. (CSRH) Enters Partnership Agreement With KO Entertainment, Inc.
- Cardium Therapeutics, Inc. (CXM) Announces Generx Publication In Molecular Therapy
- DoMark International, Inc. (DOMK) Announces Move to Protect Shareholders by Cancelling 50k Preferred Shares, 5.74M Common A Shares
- GNCC Capital, Inc. (GNCP) to Complete Acquisition
- GlobalWise Investments, Inc. (GWIV) Reports Financial Results for First Quarter 2013
- International Stem Cell Corp. (ISCO) to Host Q1 2013 Financial Results Conference Call at 11:00 a.m. ET on Tuesday, May 14, 2013
- Loans4Less.com, Inc. (LFLS) Announces Financial Results for Q1 2013
- Low Carbon Technologies International, Inc. (LWCTF) Plans to Announce 6 Month YTD Financials
- Rafarma Pharmaceuticals, Inc. (RAFA) Announces Engagement of QualityStocks Investor Relations Services
- Rainbow Coral Corp. (RBCC) World’s Premiere Science Journal Touts Revolutionary Innovations by Partner Nano3D
- The Aristocrat Group Corp. (ASCC) Targets Underserved Market for Gluten-Free Vodka
- The Guitammer Company Inc. (GTMM) Partner Wins Prestigious "ET NOW Leaders of Tomorrow Awards 2012"
- VentriPoint Diagnostics Ltd. (VPTDF) Announces Private Placements
- Viaspace, Inc. (VSPC) Giant King Grass to Biogas for Electricity Paper Presented at International Biomass Conference
- VistaGen Therapeutics, Inc. (VSTA) and Duke University Publish Results on Production of Functional 3D Human Heart Tissue